Mylan NV Stock Price - MYL

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
After Hours
Last Trade
Last $ 18.53 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Mylan NV MYL NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.215 1.17% 18.525 18.69 18.01 18.33 18.31 19:57:18
Bid Price Ask Price Spread Spread % News
18.36 18.70 0.34 1.82% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
35,173 4,955,274 $ 18.45 $ 91,413,299 5,123,194 16.63 - 37.56
Last Trade Time Type Quantity Stock Price Currency
19:41:46 2 $ 18.57 USD

Mylan NV Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 9.56B 515.87M $ 352.50M 0.68 308.80 512.47M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 10.00 0.70%

more financials information »

Mylan NV News

Loading Messages....

Latest MYL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week18.9819.1817.9018.395,532,220-0.455-2.4%
1 Month19.8720.31517.9018.794,853,979-1.35-6.77%
3 Months21.4222.9017.3119.485,710,654-2.90-13.52%
6 Months26.7228.5016.6319.927,147,284-8.20-30.67%
1 Year31.2537.5616.6324.016,196,589-12.73-40.72%
3 Years37.2547.8216.6332.885,583,971-18.73-50.27%
5 Years51.2476.68516.6340.925,662,479-32.72-63.85%

Mylan NV Description

Registered in the Netherlands, Mylan is a leading generic drugmaker, with roughly 55 manufacturing and R&D facilities. Although the company was formed in 1961, the company's position as the second- largest generic company was largely attributable to the acquisition of Matrix Laboratories and generics business of Germany-based Merck KGaA. Mylan has a portfolio of more than 7,500 generic, specialty, and over-the-counter active ingredients and medicines and is predominantly recognized for manufacturing the EpiPen (treatment for anaphylaxis), which was acquired through the Merk KGaA transaction.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.